Upregulation of AFP is commonly observed in hepatocyte regeneration, hepatocarcinogenesis, and embryonic cancers, which suggests it can function as a biomarker for diagnosing HCC [40]. This evidence concerns the gene AFP and hepatocellular carcinoma.